Latest "irbesartan amlodipine irbesartan Hypertension" News Stories

19:05 EDT 23rd July 2016 | BioPortfolio

Here are the most relevant search results for "irbesartan amlodipine irbesartan Hypertension" found in our extensive news archives from over 250 global news sources.

More Information about irbesartan amlodipine irbesartan Hypertension on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about irbesartan amlodipine irbesartan Hypertension for you to read. Along with our medical data and news we also list irbesartan amlodipine irbesartan Hypertension Clinical Trials, which are updated daily. BioPortfolio also has a large database of irbesartan amlodipine irbesartan Hypertension Companies for you to search.

Showing "irbesartan amlodipine irbesartan Hypertension" News Articles 1–25 of 940

Extremely Relevant

Human medicines European public assessment report (EPAR): Irbesartan Zentiva (previously Irbesartan Winthrop), irbesartan, Revision: 18, Authorised

Human medicines European public assessment report (EPAR): Karvea, irbesartan, Revision: 34, Authorised

Human medicines European public assessment report (EPAR): Aprovel, irbesartan, Revision: 35, Authorised

Angiotensin II receptor blocker irbesartan attenuates cardiac dysfunction induced by myocardial infarction in the presence of renal failure

Dimerix to continue supplying propagermanium to kidney disease patients

The TGA’s special access scheme has granted clinical-stage biotech company Dimerix (ASX:DXB) the right to continue supplying propagermanium to participants in its DMX-200 clinical trial, upon clinician approval and participant agreement. DMX-200 is a combination of two existing drugs: a chemokine receptor CCR2 blocker (propagermanium) used for its anti-inflammatory properties and not on the Aus...


Dimerix Receives TGA Special Access Scheme Approval to Continue to Supply Propagermanium to Kidney Patients on its DMX-200 Phase II trial

Melbourne, Australia, 19 April 2016: Dimerix Limited (ASX: DXB), a clinical-stage biotechnology company committed to discovering and developing new therapeutic treatments identified using its proprietary screening assay, today announced that the Therapeutic Goods Administration in Australia (TGA) has confirmed that Dimerix can continue to supply propagermanium to participants in the DMX-200 clin...

Sleep apnea patients with resistant hypertension may have increased risk for cardiovascular outcomes

In a study of patients with hypertension, those with resistant hypertension--meaning that their blood pressure remained elevated despite concurrent use of three antihypertensive agents of different classes--had a higher rate of sleep apnea (9.6%) than those without resistant hypertension (7.2%).

Hard-to-treat hypertension may jeopardize sleep apnea patients' heart health

In a study of patients with hypertension, those with resistant hypertension—meaning that their blood pressure remained elevated despite concurrent use of three antihypertensive agents of different classes—had a higher rate of sleep apnea (9.6%) than those without resistant hypertension (7.2%). Resistant hypertensive patients with sleep apnea had an increased risk of ischemic heart events and c...

Pulmonary Hypertension Association Launches “PH Care for All” to Investigate and Address Pulmonary Hypertension Treatment Disparities

Silver Spring, Md. (PRWEB) April 21, 2016 While the Pulmonary Hypertension Association (PHA) has seen marked progress in the treatment of pulmonary hypertension (PH) in its 25-year history, all things are not equal in the advancement of patient care. PHA has assembled 26 esteemed pulmonary hy...

Treating hypertension in patients with medical comorbidities

What you need to knowTwo out of three people with hypertension have a comorbidityThere is NICE guidance on blood pressure targets and drug therapy for patients with hypertension and comorbidities...

Postpartum Hypertension After Pregnancy-Related Hypertension

Is postpartum readmission for hypertension associated with mode of delivery? Journal of Perinatology : Official Journal of the California Perinatal Association

Cardiovascular Events Associated with Masked Hypertension and White-coat Hypertension

Analysis from the Dallas Heart Study consisting of 3027 adults revealed that both white-coat hypertension and masked hypertension were independently associated with increased cardiovascular events, and, therefore, home blood pressure monitoring is recommended for U.S. adults, whether symptomatic or asymptomatic.

Untreated hypertension increases risk for intracerebral hemorrhage

The risk for intracerebral hemorrhage is more than nine times higher for men and women with untreated hypertension compared with those with treated hypertension, researchers reported at the International Stroke Conference.Treatment of hypertension appears to have a substantial impact on risk for intracerebral hemorrhage, according to Kyle Walsh, MD, assistant professor of emergency medicine at Uni...

Effects of azelnidipine and amlodipine on exercise-induced sympathoexcitation assessed by pupillometry in hypertensive patients

Drug-resistant Hypertension? Consider Adding a Nonpharmacologic Prescription

In patients with obstructive sleep apnea and hypertension, continuous positive airway pressure use was associated with clinically and statistically significant reductions in blood pressure for both resistant and non-resistant hypertension.

PCORI approves Group Health for $2.8 million research funding award

(Group Health Research Institute) Treating hypertension is crucial to help prevent heart attacks and strokes. But treatment can harm people without hypertension. And it can be tricky to establish whether a person has 'the silent killer.' Everyone's blood pressure rises and falls dramatically during a day -- notably often rising in medical offices ('white coat hypertension'). That's why it's so imp...

Hypertension: Benefits of strict blood-pressure lowering in hypertension

A new meta-analysis by Ettehad and colleagues, which included >613,000 patients with hypertension from randomized, controlled trials, clearly demonstrates that antihypertensive medication reduces cardiovascular events and death in all patients, including those with systolic blood pressure

Orthostatic hypertension as a predisposing factor for masked hypertension: the J-SHIPP study

Hypertension: When should we treat hypertension in patients with diabetes?

Diabetes mellitus and hypertension are closely related, and guidelines have recommended aggressive treatment of hypertension in patients with diabetes. However, no single clinical trial is conclusive. An extensive review of the use of blood-pressure-lowering drugs in patients with diabetes supports treating blood pressure >140/90 mmHg, whereas reducing blood pressure in people with normal or high...

The results of a survey of physicians about the Japanese Society of Hypertension Guidelines for the Management of Hypertension 2014 and its clinical use

The High Stakes of Hypertension

Ann Aerts, Head of Novartis Foundation SOURCE: Novartis DESCRIPTION:BASEL – Most of us know about hypertension – at least we think we do. We understand that abnormally high blood pressure puts us at greater risk of heart attacks and stroke. And we also know that it is linked to diet and lifestyle, and can be treated with the right medication. But many would say that hypertension is primarily a...

Changes in BMI and Risk for Hypertension During Childhood and Adolescence

During a 3-year follow-up study, the riskiest “change” associated with developing hypertension was remaining obese.

Hypertension: IL-1 receptor-induced sodium reabsorption in hypertension

Prevalence and determinants of resistant hypertension in a sample of patients followed in Italian hypertension centers: results from the MINISAL-SIIA study program

Idiopathic (Essential) Hypertension - Pipeline Review, H1 2016

Recently added to the BioPortfolio report store, Idiopathic (Essential) Hypertension - Pipeline Review, H1 2016 is a new report from Global Markets Direct published on 2016-03-21. This 68-page report is available in PDF from $2000. Idiopathic (Essential) Hypertension - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Idiopathic (Essential) Hypertension - Pipeline Review, H1 2016’...

Quick Search

News Quicklinks